Evidence map›Paper›PMID 23443065›Full record

ArticleScientific reports2013

Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics.

Jingwei Shao, Robert J Griffin, Ekaterina I Galanzha, Jin-Woo Kim, Nathan Koonce, Jessica Webber, Thikra Mustafa, Alexandru S Biris, Dmitry A Nedosekin, Vladimir P Zharov

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 139 citations in OpenAlex.

  1. Quercetin-mediated synthesis of stable and biocompatible gold nanoparticles for enhanced photothermal therapy.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Clinical Application of Cytokines in Cancer Immunotherapy.Drug design, development and therapy · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Nanotechnology for Cancer Therapy Based on Chemotherapy.Molecules (Basel, Switzerland) · 2018
    Review
  18. Galectin-1-based tumour-targeting for gold nanostructure-mediated photothermal therapy.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2018
    Article
  19. Inflammation and Cancer: In Medio Stat Nano.Current medicinal chemistry · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jingwei ShaoCollege of Chemistry and Chemical Engineering, Fuzhou University, Fuzhou, Fujian, China.
Robert J Griffin
Ekaterina I Galanzha
Jin-Woo Kim
Nathan Koonce
Jessica Webber
Thikra Mustafa
Alexandru S Biris
Dmitry A Nedosekin
Vladimir P Zharov
University of Arkansas for Medical Sciences · USUniversity of Arkansas at Little Rock · USFuzhou University · CNUniversity of Arkansas at Fayetteville · US

Funding

PHYSIOLOGICAL FACTORS IN HYPERTHERMIAR01CA044114 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI GRIFFIN, ROBERT JAMES · 1987 to 2012
$3.3M
In vivo real-time detection of circulating melanoma cellsR01CA131164 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI SUEN, JAMES · 2009 to 2019
$3.1M
Multifunctional nanotubes for in vivo detecting/purging circulating cancer cellsR01EB009230 · NIBIB · UNIV OF ARKANSAS FOR MED SCIS · PI ZHAROV, VLADIMIR P · 2009 to 2012
$1.2M
Photothermal Imaging of Live CellsR01EB000873 · NIBIB · UNIV OF ARKANSAS FOR MED SCIS · PI ZHAROV, VLADIMIR P · 2005 to 2008
$1.1M
In vivo molecular laser detection and treatment of circulating cancer stem cellsR21CA139373 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI ZHAROV, VLADIMIR P · 2009 to 2010
$329k
NCI NIH HHS R01 CA044114NCI NIH HHS R01 CA131164NCI NIH HHS R01CA131164NCI NIH HHS R01CA44114NCI NIH HHS R21 CA139373NCI NIH HHS R21CA139373NIBIB NIH HHS R01 EB000873NIBIB NIH HHS R01EB000873NIBIB NIH HHS R01 EB009230NIBIB NIH HHS R01EB009230
6 · The paper itself

Abstract

Nanotechnology has been extensively explored for drug delivery. Here, we introduce the concept of a nanodrug based on synergy of photothermally-activated physical and biological effects in nanoparticle-drug conjugates. To prove this concept, we utilized tumor necrosis factor-alpha coated gold nanospheres (Au-TNF) heated by laser pulses. To enhance photothermal efficiency in near-infrared window of tissue transparency we explored slightly ellipsoidal nanoparticles, its clustering, and laser-induced nonlinear dynamic phenomena leading to amplification and spectral sharpening of photothermal and photoacoustic resonances red-shifted relatively to linear plasmonic resonances. Using a murine carcinoma model, we demonstrated higher therapy efficacy of Au-TNF conjugates compared to laser and Au-TNF alone or laser with TNF-free gold nanospheres. The photothermal activation of low toxicity Au-TNF conjugates, which are in phase II trials in humans, with a laser approved for medical applications opens new avenues in the development of clinically relevant nanodrugs with synergistic antitumor theranostic action.

Indexed as

GoldNanospheresAnimalsAntineoplastic AgentsCell Line, TumorDisease Models, AnimalDrug CarriersHot TemperatureLasersLightMiceNeoplasmsPhototherapyTumor Necrosis Factor-alphaAntineoplastic AgentsDrug CarriersGoldTumor Necrosis Factor-alpha

Identifiers

PMID23443065
PMCPMC3582999
OpenAlexW2082689979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.